Clarivate (NYSE:CLVT) Releases FY25 Earnings Guidance

Clarivate (NYSE:CLVT) updated its FY25 earnings guidance on Wednesday. The company provided earnings per share guidance of $0.60-$0.70 for the period, compared to the consensus earnings per share estimate of $0.73. The company issued revenue guidance of $2.28-$2.40 billion, compared to the consensus revenue estimate of $2.53 billion. Clarivate also updated its FY 2025 guidance to 0.600-0.700 EPS.

Analyst Upgrades and Downgrades

CLVT has been the subject of several recent analyst reports. Barclays cut their target price on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research report on Thursday, November 7th. Royal Bank of Canada reduced their target price on shares of Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a report on Thursday, November 7th. Finally, William Blair cut shares of Clarivate from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Clarivate presently has an average rating of “Hold” and an average price target of $7.10.

Clarivate Trading Down 1.6 %

Shares of NYSE:CLVT traded down $0.08 during mid-day trading on Wednesday, hitting $4.76. The company had a trading volume of 20,544,830 shares, compared to its average volume of 5,205,901. The company has a market capitalization of $3.38 billion, a PE ratio of -2.39 and a beta of 1.17. Clarivate has a one year low of $4.22 and a one year high of $9.07. The firm has a fifty day moving average price of $5.15 and a 200 day moving average price of $5.82. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.88 and a quick ratio of 0.88.

Clarivate declared that its Board of Directors has authorized a share repurchase program on Monday, December 16th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 12.8% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Insider Transactions at Clarivate

In other news, Director Michael J. Angelakis bought 765,000 shares of the stock in a transaction dated Friday, November 22nd. The stock was bought at an average price of $5.19 per share, for a total transaction of $3,970,350.00. Following the completion of the acquisition, the director now directly owns 3,465,000 shares in the company, valued at approximately $17,983,350. This trade represents a 28.33 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 23.14% of the stock is currently owned by insiders.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.